98%
921
2 minutes
20
Background: The prognostic impact of complete coronary revascularization relative to non-invasive testing methods is unknown.
Objectives: To assess the association between completeness of revascularization defined by CTA-derived fractional flow reserve (FFR) and cardiovascular outcomes in patients with stable angina.
Methods: Multicenter 3-year follow-up study of patients with new onset stable angina and ≥ 30% stenosis by CTA. The lesion-specific FFR value (two cm-distal-to-stenosis) was registered in all vessels with stenosis and considered abnormal when ≤ 0.80. Patients with FFR ≤ 0.80 were categorized as: Completely revascularized (CR-FFR), all vessels with FFR ≤ 0.80 revascularized; incompletely revascularized (IR-FFR), ≥ 1 vessels with FFR ≤ 0.80 non-revascularized. Early revascularization (< 90 days from index CTA) categorized vessels as revascularized. The primary endpoint comprised cardiovascular death and non-fatal myocardial infarction; the secondary endpoint vessel-specific late revascularization and non-fatal myocardial infarction.
Results: Amongst 900 patients and 1759 vessels, FFR was ≤ 0.80 in 377 (42%) patients, 536 (30%) vessels; revascularization was performed in 244 (27%) patients, 340 (19%) vessels. Risk of the primary endpoint was higher for IR-FFR (15/210 [7.1%]) compared to CR-FFR (4/167 [2.4%]), RR: 2.98; 95% CI: 1.01-8.8, p = 0.036, and to normal FFR (3/523 [0.6%]), RR: 12.45; 95% CI: 3.6-42.6, p < 0.001. Incidence of the secondary endpoint was higher in non-revascularized vessels with FFR ≤ 0.80 (29/250 [12%]) compared to revascularized vessels with FFR ≤ 0.80 (5/286 [1.7%]), p = 0.001, and to vessels with FFR > 0.80 (10/1223 [0.8%]), p < 0.001.
Conclusion: Incomplete revascularization of patients with lesion-specific FFR ≤ 0.80 is associated to unfavorable cardiovascular outcomes compared to those with complete revascularization or FFR > 0.80.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.jcct.2024.07.007 | DOI Listing |
J Vasc Surg
January 2025
Department of Surgery, Division of Vascular and Endovascular Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA. Electronic address:
Objective: Several studies comparing the transperitoneal (TP) and retroperitoneal (RP) approach for abdominal aortic aneurysm (AAA) repair suggest that the RP approach may result in lower rates of perioperative mortality and morbidity. However, data comparing these approaches for open conversion are lacking. This study aims to evaluate the association between the type of approach and outcomes following open conversion after endovascular aneurysm repair (EVAR).
View Article and Find Full Text PDFJ Endovasc Ther
August 2024
Department of Vascular Surgery, Erasmus Medical Centre, Rotterdam, The Netherlands.
Purpose: Metformin, widely used for the treatment of diabetes mellitus (DM), has shown potential for inhibiting abdominal aortic aneurysm (AAA) growth by reducing extracellular matrix remodeling and inflammation. However, its influence on clinical outcomes and aneurysm sac dynamics after endovascular aneurysm repair (EVAR) remains uncertain. This retrospective study aims to explore the effects of metformin on long-term outcomes following EVAR.
View Article and Find Full Text PDFJ Clin Med
June 2024
Department of Cardiovascular and Thoracic Surgery, University Hospital of Liège, 4000 Liège, Belgium.
Diabetes has a protective effect on abdominal aortic aneurysms (AAAs); however, there are contrasting reports on the impact of diabetes on endovascular aortic repair (EVAR) outcomes, endoleaks (ELs) being the major negative outcome. The present study characterizes ELs and their outcomes in AAA patients, diabetic or not. This single-center, retrospective, comparative study was carried out on 324 AAA patients who underwent elective EVARs between 2007 and 2016 at the University Hospital of Liège (Belgium).
View Article and Find Full Text PDFJ Clin Med
February 2024
Clinic for Vascular and Endovascular Surgery, Medical Faculty and University Hospital Düsseldorf, 40225 Düsseldorf, Germany.
An intraluminal, non-occlusive thrombus (ILT) is a common feature in an abdominal aortic aneurysm (AAA). This study investigated the relative progression of ILT vs. AAA volume using a novel parameter, the so-called thrombus burden ratio (TBR), in non-treated AAAs.
View Article and Find Full Text PDFSci Rep
February 2024
SDS Optic, EcoTech Complex, Block A, Głęboka 39, 20-612, Lublin, Poland.
The expression of the HER2 (human epidermal growth factor receptor 2) protein in cancer cells is a well-established cancer marker used for diagnostic and therapeutic purposes in modern treatment protocols, especially in breast cancer. The gold-standard immunohistochemical diagnostic methods with the specific anti-HER2 antibodies are utilized in the clinic to measure expression level of the membrane-bound receptor. However, a soluble extracellular domain (ECD) of HER2 is released to the extracellular matrix, thus the blood assays for HER2 measurements present an attractive way for HER2 level determination.
View Article and Find Full Text PDF